WSOPRAS and ITEDS Consensus Statement on the Assessment and Management of Thyroid Eye Disease
6 affiliations
- 1Department of Ophthalmology, Byers Eye Institute, Stanford University School of Medicine. Palo Alto, California, U.S.A.
- 2Vision Eye Centers and Department of Ophthalmology, Sir Ganga Ram Hospital, New Delhi, India
- 3Department of Ophthalmology, Ribeirão Preto Medical School, Hospital das Clínicas-Campus, Ribeirão Preto, Brazil
- 4Department of Ophthalmology, Catholic University of Louvain, Academic Hospital Saint Luc, Brussels, Belgium
- 5Department of Ophthalmology, Edward S Harkness Eye Institute, Columbia University, New York, New York, U.S.A.
- 6Division of Ophthalmology, Department of Surgery, University of Queensland, St Lucia, Queensland, Australia.
Abstract
Purpose:: To develop a globally applicable consensus statement for the assessment and management of thyroid eye disease (TED).
Methods:: The World Society of Ophthalmic Plastic Reconstructive and Aesthetic Surgery council selected a 6-member, geographically diverse TED task force to develop a consensus statement on the assessment and management of TED. Consensus was achieved through monthly meetings from January to July 2025, alongside an analysis of the literature in terms of relevance, level of evidence, and global versus local applicability. A draft document was circulated to all World Society of Ophthalmic Plastic Reconstructive and Aesthetic Surgery constituent societies for feedback. Using a modified Delphi approach, the expert panel convened over 6 additional virtual sessions from July 2025 to March 2026 to review the submitted feedback, incorporating comments with agreement from at least 5 of 6 experts. The final statement was approved by both the World Society of Ophthalmic Plastic Reconstructive and Aesthetic Surgery council and the International Thyroid Eye Disease Society board of directors.
Results:: Consensus was achieved regarding methods, TED definitions, assessment, medical and surgical management, and safety recommendations. The consensus statement delineates acceptable standards, workup, and evaluation time points for basic-, intermediate-, and advanced-level assessment tailored to diverse global contexts, as well as tiered medical and surgical interventions, recommended for the different phases and severities of TED.
Conclusions:: The World Society of Ophthalmic Plastic Reconstructive and Aesthetic Surgery-International Thyroid Eye Disease Society consensus statement on TED, developed by oculoplastic and orbital surgeons, provides a global framework for the standardized assessment and management of TED to improve TED care and enhance patient outcomes.
Related
- Prevention and management of bleeding complications in interventional ultrasound: an international expert consensus statement
- Management of Heart transplant recipients for the non Heart Transplant health care provider. A Clinical Consensus Statement of the Heart Failure Association (HFA) and the Association of Cardiovascular Nursing & Allied Professions (ACNAP) of the ESC
- Comment on Rapone et al. Consensus Statement on Full-Arch Implant Rehabilitations: Evidence-Based Recommendations from the Italian Consensus Conference. J. Clin. Med. 2026, 15, 3695
- The European Association of Neuro-Oncology consensus statement on radiation necrosis
- Statement of Retraction: Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1.
BibTeX
@article{kossler2026wsopras,
title = {{WSOPRAS and ITEDS Consensus Statement on the Assessment and Management of Thyroid Eye Disease}},
author = {Andrea L. Kossler and Ashok K. Grover and Antonio A.V. Cruz and Lelio Baldeschi and Michael Kazim and Timothy J. Sullivan},
journal = {Ophthalmic Plastic and Reconstructive Surgery},
year = {2026},
month = sep,
doi = {10.1097/iop.0000000000003277},
url = {https://doi.org/10.1097/iop.0000000000003277},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - WSOPRAS and ITEDS Consensus Statement on the Assessment and Management of Thyroid Eye Disease
AU - Andrea L. Kossler
AU - Ashok K. Grover
AU - Antonio A.V. Cruz
AU - Lelio Baldeschi
AU - Michael Kazim
AU - Timothy J. Sullivan
PY - 2026
DA - 2026/09/02
JO - Ophthalmic Plastic and Reconstructive Surgery
DO - 10.1097/iop.0000000000003277
UR - https://doi.org/10.1097/iop.0000000000003277
AB - Purpose:: To develop a globally applicable consensus statement for the assessment and management of thyroid eye disease (TED). Methods:: The World Society of Ophthalmic Plastic Reconstructive and Aesthetic Surgery council selected a 6-member, geographically diverse TED task force to develop a consensus statement on the assessment and management of TED. Consensus was achieved through monthly meetings from January to July 2025, alongside an analysis of the literature in terms of relevance, level of evidence, and global versus local applicability. A draft document was circulated to all World Society of Ophthalmic Plastic Reconstructive and Aesthetic Surgery constituent societies for feedback. Using a modified Delphi approach, the expert panel convened over 6 additional virtual sessions from July 2025 to March 2026 to review the submitted feedback, incorporating comments with agreement from at least 5 of 6 experts. The final statement was approved by both the World Society of Ophthalmic Plastic Reconstructive and Aesthetic Surgery council and the International Thyroid Eye Disease Society board of directors. Results:: Consensus was achieved regarding methods, TED definitions, assessment, medical and surgical management, and safety recommendations. The consensus statement delineates acceptable standards, workup, and evaluation time points for basic-, intermediate-, and advanced-level assessment tailored to diverse global contexts, as well as tiered medical and surgical interventions, recommended for the different phases and severities of TED. Conclusions:: The World Society of Ophthalmic Plastic Reconstructive and Aesthetic Surgery-International Thyroid Eye Disease Society consensus statement on TED, developed by oculoplastic and orbital surgeons, provides a global framework for the standardized assessment and management of TED to improve TED care and enhance patient outcomes.
SN - 0740-9303
SN - 1537-2677
ER -